News

The study explored the intervention’s effects using both quantitative and qualitative methods.

Check out this guide for supporting youth in their social media use.

The senior vice president of research at the American Foundation for Suicide Prevention offers thoughts on suicide and students.

The drug’s developers respond to the FDA’s decision to deny approval and consider future directions for this indication.

What is the association between cannabis use disorders and schizophrenia? Researchers used a nationwide register-based cohort study to investigate these associations.

Should everyone receive psychotherapy?

How is sailing similar to treating mood disorders?

In honor of Labor Day 2023, here are some recent expert discussions on burnout prevention as seen in Psychiatric Times®.

As we enter fall, we want to know what you're excited about in psychiatry!

From new research on psilocybin as a treatment for MDD to new FDA approvals for ADHD and BED, here are highlights from the week in Psychiatric Times.

What is new in research on transcranial magnetic stimulation?

The experts weighed in on a wide variety of psychiatric issues for the August 2023 issue of Psychiatric Times.

Celebrating 2 years of “Psychiatric Views on the Daily News”!

The treatment was well-tolerated, and no serious treatment-emergent adverse effects were identified.

Let us introduce you to the organization who wants to promote the professional development of psychiatrists as leaders.

Today is International Overdose Awareness Day!

Three eulogies for the Labor Day weekend.

A psychiatrist has an undeniable response to the Jacksonville shooting.

Let's think about the positives in psychiatry...

The funds will be distributed over the course of 5 years to support preclinical through phase 2 studies.

In this insightful interview, experts discuss the journey toward a more humanistic approach in psychiatry, the challenges of integrating biological and psychosocial aspects, and the need for comprehensive training for future psychiatrists.

Generics are now approved for adults in the treatment of BED and for individuals aged 6 years and older in the treatment of ADHD.

How can clinicians recognize and acknowledge the injustices often experienced by COVID long-haulers?

A recent survey found mental health and finances were some of the top stressors for college students.

Travel: a state of mind.

Patient suicide is both personally challenging and legally complicated for mental health professionals. Are you providing the standard of care? How do you balance confidentiality and family support? When is split treatment justified by reduced liability exposure? Difficult questions — but not impossible. Download this guide, provided by Professional Risk Management Services® (PRMS®), for proven risk management and patient safety approaches.

As we commemorate the landmark March on Washington, parallels are drawn between Dr Martin Luther King Jr's dreams of equality and the goals of social psychiatry, highlighting the need to address social determinants of mental health.

“The Genain quadruplets have really gone down in psychiatric history for being the ‘poster girls’ for psychiatric genetics.”

Researchers investigated the prevalence and correlates of sleep disorders in patients with first-episode psychosis.

From informed consent in treatment with psychedelics to an anti-fentanyl antibody that may reverse the signs of carfentanil overdose, here are highlights from the week in Psychiatric Times.